Idiopathic Pulmonary Fibrosis (IPF): Risk Factors and Diagnosis

GB0139 (formerly TD139): A potential therapeutic for IPF?

So You've Been Diagnosed with Pulmonary Fibrosis...What's Next?

Pulmonary Fibrosis: Everything You Need To Know

Idiopathic Pulmonary Fibrosis | Restrictive Lung Disease | Pulmonology

ADD/ADHD | What Is Attention Deficit Hyperactivity Disorder?

Interstitial Lung Disease (ILD) in a Nutshell

What is Idiopathic Pulmonary Fibrosis (IPF)?

Living with IPF - what is it really like?

What is Pulmonary Fibrosis and Why is it a Problem? | Joyce Lee, MD

Restrictive Lung Diseases - Interstitial Pulmonary Fibrosis. Pathology, Clinical, Tests, Treatment

Saracatinib Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis

Anti-Inflammatory & Immunosuppressive Medications Webinar

Chronic and Progressive | Idiopathic Pulmonary Fibrosis | MedscapeTV

3-5 year survival in Idiopathic Pulmonary Fibrosis (IPF)?

Idiopathic Pulmonary Fibrosis - pathophysiology, signs and symptoms, investigation and treatment

Progressive Pulmonary Fibrosis: What Patients Need to Know webinar

Understanding Chronic Obstructive Pulmonary Disease (COPD Explained Clearly)

How to Recognize and Diagnose IPF

What is the Life Expectancy of Idiopathic Pulmonary Fibrosis?

Overview of Pirfenidone and Nintedanib | Joyce Lee, MD